---
title: "SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT)"
ocid: "ocds-h6vhtk-034881"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-034881"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-034881.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-034881.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "MINISTRY OF DEFENCE"
published: "2023-05-03"
---

# SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT)

Buyer: MINISTRY OF DEFENCE  
Current stage: Award  
OCID: ocds-h6vhtk-034881

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-034881)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-034881.json)

## Summary

The Ministry of Defence in the United Kingdom has completed a procurement process for the supply of Heptavalent Botulism Antitoxin (HBAT) with Emergent Biosolutions Canada Inc. This contract falls under the goods category and was awarded through a negotiated procedure without publication of a contract notice. The contract, valued at £20m for 10 years, aims to maintain the UK Ministry of Defence's capability in Chemical, Biological, Radiological, and Nuclear (CBRN) defence.

This tender presents a significant business opportunity for suppliers in the immunoglobulins industry, particularly those with expertise in manufacturing antitoxins. The competitive landscape is limited due to the technical requirements of the product, making Emergent Biosolutions Canada Inc, as the sole licensed manufacturer of HBAT, the exclusive provider of this critical capability to the Ministry of Defence. Businesses with capabilities in supplying specialised immunoglobulins for CBRN defence applications will find this tender well-suited for their operations.

## Notice

The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), has placed a contract with Emergent Biosolutions Canada Inc for the supply of Heptavalent Botulism Antitoxin (HBAT) for a period of 3 years. This is necessary to ensure maintenance of the capability with an acceptable stockholding level.

### Lot Information

Lot 1

The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), intends to place a contract with Emergent for the supply of Heptavalent Botulism Antitoxin (HBAT) for a period of 10 years (5 + 5 Option Years) with an estimated value of PS20M+. This is necessary to ensure maintenance of the capability with an acceptable stockholding level. Due to the estimated contract value and on the basis that it is to be placed directly with Emergent Biosolutions Canada Inc, the contract will be a Qualifying Defence Contract (QDC) and shall comply with the Single Source Contract Regulations (SSCR) 2014. It is considered that this contract can be awarded using the negotiated procedure without prior publication of a contract notice, pursuant to Public Contracts Regulations 2015; where "Regulation 32 (2)(b)(ii) allows you to use the Negotiated procedure without Prior Publication when the exclusivity is due to technical reasons". Summary of the Technical Reason: Emergent Biosolutions Canada Inc are currently the only licensed manufacturer for HBAT (BAT(r)) which provides antitoxin serotypes A-G for treatment of Botulism worldwide. This product is therefore the only product which provides the full capability to Defence. Additional information: Due to the limitations of the character limit at II 2.4) Description -- it is not possible to enter the full details of the single source justification, for full details of the reasoning, please email Tamika.Kelly116@mod.gov.uk so that it can be forwarded to you.

Options: 5 Optional Years

### Procurement Information

It is considered that this contract can be awarded using the negotiated procedure without prior publication of a contract notice, pursuant to Public Contracts Regulations 2015; where "Regulation 32 (2)(b)(ii) allows you to use the Negotiated procedure without Prior Publication when the exclusivity is due to technical reasons". Summary of the Technical Reason: Emergent Biosolutions Canada Inc are currently the only licensed manufacturer for HBAT (BAT(r)) which provides antitoxin serotypes A-G for treatment of Botulism worldwide. This product is therefore the only product which provides the full capability to Defence.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/012644-2023 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Negotiated without publication of a contract notice |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 May 2023 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 6 Jun 2022 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £34,955,456 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | MINISTRY OF DEFENCE |
| Locality | BRISTOL |
| Post town | Bristol |
| Postcode | BS34 8JH |
| Country | England |
| ITL 1 | TLK South West (England) |
| ITL 2 | TLK5 West of England |
| ITL 3 | TLK52 Bath & North East Somerset and South Gloucestershire |
| Local authority | South Gloucestershire |
| Electoral ward | Stoke Park & Cheswick |
| Westminster constituency | Filton and Bradley Stoke |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | EMERGENT BIOSOLUTIONS CANADA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651520 - Immunoglobulins

## Release History

- 3 May 2023 at 11:45 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/012644-2023
- 20 Jun 2022 at 15:30 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/016860-2022

## Notice URLs

- https://www.gov.uk/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-034881. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-034881.json.